This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Adult fibroblast
Blood
Bone marrow CD34+ cells
Bone marrow-derived mesenchymal stem cell (R14)
Breast cancer cell (MCF7)
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Caput luminal fluid
Cauda luminal fluid
Colon cancer cell (HCT116)
Colon cancer cell (HT29)
Colon cancer cell (RKO)
Colon cancer cell (SW48)
Colon cancer cell (SW480)
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Embryonic kidney cell (HEK293T)
Fetal human colon epithelial cell (FHC)
Gastric cancer cells (SGC-7901)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cells (A549)
Malignant melanoma cell (A375)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Oral cancer cells (HOC313-LM)
Oral cancer cells (HOC313-P)
Plasma
Saliva
Seminal plasma
Serum
By sample status
24 hr culture
72 hr culture
Acute myeloid leukemia
Cisplatin-resistant
Colorectal cancer_stage1
Colorectal cancer_stage1_after_resection
Colorectal cancer_stage2
Colorectal cancer_stage2_after_resection
Colorectal cancer_stage3a
Colorectal cancer_stage3a_after_resection
Colorectal cancer_stage3b
Colorectal cancer_stage3b_after_resection
Colorectal cancer_stage4
Colorectal cancer_stage4_after_resection
Electroporated with Dicer antibody
Extremely severe hand, foot, and mouth disease
Fetal bovine serum
Healthy_timepoint1
Healthy_timepoint2
Mild hand, foot, and mouth disease
Normal
Normal_Agilent
Omeprazole-treated
Oral lichen planus patient
Pancreatic cancer patient_Agilent
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Transplant islets into mouse xenotransplantation
Transplant islets into mouse xenotransplantation-rejected
Vasectomy
Vasovasostomy
shDicer-transfected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-1268a
MIMAT0005922
0.0e+0
2.9e-6
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
7.7e-8
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
ppy-miR-1268
MIMAT0016192
0.0e+0
5.1e-8
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
7.5e-4
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
ppy-miR-1268
MIMAT0016192
0.0e+0
1.3e-8
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
2.6e-8
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
ppy-miR-1268
MIMAT0016192
0.0e+0
1.1e-6
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
5.3e-10
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
ppy-miR-1268
MIMAT0016192
0.0e+0
5.0e-11
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
8.5e-7
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
4.1e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
ppy-miR-1268
MIMAT0016192
0.0e+0
7.8e-3
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
7.8e-6
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
ppy-miR-1268
MIMAT0016192
0.0e+0
8.2e-14
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
1.3e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
ppy-miR-1268
MIMAT0016192
0.0e+0
1.3e-3
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
8.5e-9
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
ppy-miR-1268
MIMAT0016192
0.0e+0
1.5e-11
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
1.5e-6
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
ppy-miR-1268
MIMAT0016192
0.0e+0
6.6e-14
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
6.5e-2
Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
5.5e-4
Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
3.7e-12
3.1e-1
Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
5.6e-8
3.0e-1
Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
2.6e-2
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
8.4e-2
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
3.9e-2
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
0.0e+0
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
4.2e-2
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
5.1e-3
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
1.0e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
1.7e-2
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
1.9e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
7.8e-3
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
2.0e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
7.8e-3
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
4.5e-2
4.5e-2
Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis.
Nat Commun. 2018 Jan 2;9(1):17. doi: 10.1038/s41467-017-02406-2.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
7.3e-8
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
0.0e+0
1.8e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
4.2e-4
4.2e-4
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000946_1
71
/
0
/
71
hsa-miR-1268a
MIMAT0005922
4.7e-4
4.7e-4
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000946_1
71
/
0
/
71
<
[5]